• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙利度胺对T细胞亚群中OX40、4-1BB和糖皮质激素诱导肿瘤坏死因子受体(GITR)表达的作用

Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.

作者信息

Kim B S, Kim J Y, Kim E J, Lee J G, Joo D J, Huh K H, Kim M S, Kim Y S

机构信息

The Research Institute for Transplantation, Yonsei University College of Medicine Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.

The Research Institute for Transplantation, Yonsei University College of Medicine Seoul, Republic of Korea.

出版信息

Transplant Proc. 2016 May;48(4):1270-4. doi: 10.1016/j.transproceed.2015.12.088.

DOI:10.1016/j.transproceed.2015.12.088
PMID:27320601
Abstract

BACKGROUND

Thalidomide (TM) is known to have anti-cancer and anti-inflammatory properties; however, its mechanism on T cells is still unclear. We previously showed the immune modulatory effect of TM on T cells and its therapeutic effect on lupus nephritis models. Here we examined the changes in the expression of tumor necrosis factor receptor superfamilies (TNFRSFs), including OX40, 4-1BB, and glucocorticoid-induced TNFR-related protein (GITR) in T cell subsets by TM treatments.

METHODS

Splenic naïve T cells (Tnaives) from C57BL/6 mice were sort-purified and cultured for CD4(+) T cell proliferation and regulatory T cells (Tregs) conversion with TM treatments. All samples were analyzed by flow cytometry after stained with anti-mouse CD4, Foxp3, OX40, 4-1BB, or GITR antibodies.

RESULTS

Expressions of OX40, 4-1BB, and GITR on CD4(+) T cells showed a decreasing tendency by TM treatments. Especially, downregulation of these molecules on CD4(+)CFSE(low) T cells was significant in TM treatment groups. On the condition of Treg conversion, OX40 was downregulated significantly. In contrast, the expression of GITR was increased, and that of 4-1BB had shown no particular change under the condition of Treg.

CONCLUSION

Considering these results, TM may have an immune modulatory role through the T cell subset-specific change of OX40, 4-1BB, and GITR expression. Further study is required to elucidate the effect of thalidomide on T cells.

摘要

背景

沙利度胺(TM)具有抗癌和抗炎特性;然而,其对T细胞的作用机制仍不清楚。我们之前展示了TM对T细胞的免疫调节作用及其对狼疮性肾炎模型的治疗效果。在此,我们通过TM处理研究了肿瘤坏死因子受体超家族(TNFRSFs),包括OX40、4-1BB和糖皮质激素诱导的TNFR相关蛋白(GITR)在T细胞亚群中表达的变化。

方法

对C57BL/6小鼠的脾脏初始T细胞(Tnaives)进行分选纯化,并通过TM处理培养以促进CD4(+) T细胞增殖和调节性T细胞(Tregs)转化。用抗小鼠CD4、Foxp3、OX40、4-1BB或GITR抗体染色后,所有样本通过流式细胞术进行分析。

结果

通过TM处理,CD4(+) T细胞上OX40、4-1BB和GITR的表达呈下降趋势。特别是,在TM处理组中,CD4(+)CFSE(low) T细胞上这些分子的下调显著。在Treg转化条件下,OX40显著下调。相反,在Treg条件下,GITR的表达增加,而4-1BB的表达没有特别变化。

结论

考虑到这些结果,TM可能通过OX40、4-1BB和GITR表达的T细胞亚群特异性变化发挥免疫调节作用。需要进一步研究以阐明沙利度胺对T细胞的作用。

相似文献

1
Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.沙利度胺对T细胞亚群中OX40、4-1BB和糖皮质激素诱导肿瘤坏死因子受体(GITR)表达的作用
Transplant Proc. 2016 May;48(4):1270-4. doi: 10.1016/j.transproceed.2015.12.088.
2
Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.沙利度胺与地塞米松联合治疗对T细胞亚群的免疫调节作用增强
Immunology. 2017 Dec;152(4):628-637. doi: 10.1111/imm.12804. Epub 2017 Aug 23.
3
Immune modulatory effect of thalidomide on T cells.沙利度胺对T细胞的免疫调节作用。
Transplant Proc. 2015 Apr;47(3):787-90. doi: 10.1016/j.transproceed.2014.12.038.
4
Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.系统性红斑狼疮中不同T细胞亚群上异常的糖皮质激素诱导肿瘤坏死因子受体表达及其受糖皮质激素的调控
Int J Rheum Dis. 2016 Feb;19(2):199-204. doi: 10.1111/1756-185X.12451. Epub 2014 Oct 7.
5
Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.靶向人 OX40 的抗体可扩增效应 T 细胞,并阻断诱导型和天然调节性 T 细胞的功能。
J Immunol. 2013 Oct 1;191(7):3641-50. doi: 10.4049/jimmunol.1202752. Epub 2013 Sep 6.
6
GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.GITR 依赖性调节 4-1BB 表达:对 T 细胞记忆和抗 4-1BB 诱导的病理的影响。
J Immunol. 2013 May 1;190(9):4627-39. doi: 10.4049/jimmunol.1201854. Epub 2013 Mar 27.
7
TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.TNF 通过诱导 TNF 受体超家族成员 TNFR2、4-1BB 和 OX40 来最优地激活调节性 T 细胞。
Eur J Immunol. 2011 Jul;41(7):2010-20. doi: 10.1002/eji.201041205.
8
CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.CD4(+) CD25(low) GITR(+) 细胞:一种具有调节活性的新型人 CD4(+) T 细胞群。
Eur J Immunol. 2011 Aug;41(8):2269-78. doi: 10.1002/eji.201040943. Epub 2011 Jul 4.
9
T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.病毒感染和癌症免疫治疗期间 GITR 和 4-1BB 的 T 细胞内在作用。
Immunol Rev. 2011 Nov;244(1):197-217. doi: 10.1111/j.1600-065X.2011.01063.x.
10
Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.CD4(+)CD25+ T细胞上OX40(CD134)的激活会阻断其抑制活性:OX40的一种新调节作用及其与糖皮质激素诱导的肿瘤坏死因子受体(GITR)的比较
Blood. 2005 Apr 1;105(7):2845-51. doi: 10.1182/blood-2004-07-2959. Epub 2004 Dec 9.

引用本文的文献

1
Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures.不断发展的用于癌症治疗的嵌合抗原受体T细胞疗法:从科学发现到治愈。
Cancers (Basel). 2023 Dec 20;16(1):39. doi: 10.3390/cancers16010039.
2
Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers.沙利度胺与S-1同步放化疗治疗食管癌的疗效及其对血清肿瘤标志物的影响
World J Gastrointest Oncol. 2023 Jul 15;15(7):1262-1270. doi: 10.4251/wjgo.v15.i7.1262.
3
The apoptotic effects of NK-92 cells stimulated with an anti-CD226 antibody on MDA-MB-231 triple-negative breast cancer cells.
抗CD226抗体刺激的NK-92细胞对MDA-MB-231三阴性乳腺癌细胞的凋亡作用。
Med Oncol. 2023 Jul 6;40(8):228. doi: 10.1007/s12032-023-02080-z.
4
CAR-T cell combination therapy: the next revolution in cancer treatment.嵌合抗原受体T细胞(CAR-T)联合疗法:癌症治疗的下一次革命。
Cancer Cell Int. 2022 Nov 24;22(1):365. doi: 10.1186/s12935-022-02778-6.
5
The Immunomodulating Effects of Thalidomide and Dexamethasone in a Murine Cardiac Allograft Transplantation Model.沙利度胺和地塞米松在小鼠同种异体心脏移植模型中的免疫调节作用。
Yonsei Med J. 2022 Feb;63(2):158-165. doi: 10.3349/ymj.2022.63.2.158.
6
Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells.沙利度胺和地塞米松联合治疗对 T 细胞和其他免疫细胞的系统免疫调节作用。
Yonsei Med J. 2021 Feb;62(2):137-148. doi: 10.3349/ymj.2021.62.2.137.
7
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer.OX40(CD134)和OX40配体,癌症中的重要免疫检查点。
Onco Targets Ther. 2019 Sep 6;12:7347-7353. doi: 10.2147/OTT.S214211. eCollection 2019.
8
Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.沙利度胺与地塞米松联合治疗对T细胞亚群的免疫调节作用增强
Immunology. 2017 Dec;152(4):628-637. doi: 10.1111/imm.12804. Epub 2017 Aug 23.